ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

TAZ Regulates the Cisplatin Resistance of Epithelial Ovarian Cancer Cells via the ANGPTL4/SOX2 Axis

Li, Caihong*; Wang, Qin; Luo, Youzhen; Xiang, Juan1
Analytical Cellular Pathology-Cellular Oncology2022-9-22DOI: 10.1155/2022/5632164
1被引4阅读
引用收藏
分享

摘要

Objective. Epithelial ovarian cancer (EOC) is a fatal gynecological malignancy. This study explored the mechanism of TAZ in regulating drug sensitivity of cisplatin (DDP-)-resistant EOC cells through the ANGPTL4/SOX2 axis. Methods. The A2780/DDP cells were prepared by stepwise progressive concentration method. The drug resistance and TAZ expression in EOC cells were determined. Drug sensitivity was measured after TAZ overexpression in A2780 cells and TAZ downregulation in A2780/DDP cells, respectively. The effects of TAZ knockdown on apoptosis rate, stemness, and cancer stem cell (CSC) marker (CD44, OCT4, and ALDH1A) levels in A2780/DDP and DDP-treated A2780/DDP cells were assessed. The binding of TAZ and ANGPTL4 was verified using ChIP-qPCR, and ANGPTL4 and SOX2 levels were determined. The effects of different combined treatments of TAZ, ANGPTL4, and SOX2 on drug sensitivity of A2780/DDP cells and DDP-treated A2780/DDP cells were evaluated. Results. TAZ was upregulated in drug-resistant EOC cells. TAZ knockdown significantly increased the drug sensitivity of A2780/DDP cells, while TAZ overexpression markedly decreased the drug sensitivity of A2780 cells. TAZ silencing promoted apoptosis of drug-resistant EOC cells and inhibited cell stemness. TAZ targeted ANGPTL4 and TAZ silencing enhanced drug sensitivity of A2780/DDP cells by inhibiting ANGPTL4. ANGPTL4 overexpression elevated SOX2 expression, and SOX2 downregulation reduced the drug resistance and promoted the apoptosis of A2780/DDP cells. Conclusion. TAZ regulates DDP sensitivity of drug-resistant EOC cells via the ANGPTL4/SOX2 axis.

学科与关键词

关键词
HIPPO PATHWAYFACTOR SOX2PROLIFERATIONYAPEXPRESSIONSURVIVALHEAD
相关
加载中…
  • Aberrant epigenetic regulation of FZD3 by TET2 is involved in ovarian cancer cell resistance to cisplatin
    Zhu, Li; Zhou, Qian*JOURNAL OF CHEMOTHERAPY, 2023.
  • Blockade of ALDH in Cisplatin-Resistant Ovarian Cancer Stem Cells In Vitro Synergistically Enhances Chemotherapy-Induced Cell Death
    Guo, Fang; Yang, Zhi; Sehouli, Jalid; Kaufmann, Andreas M.*Current Oncology, 2022, 29(4): 2808-2822.被引 9
  • Anlotinib induces apoptosis and second growth/mitosis phase block in cisplatin-resistant ovarian cancer cells via the aurora kinase A/p53 pathway
    Wang, Hongli*; Wang, YuHuman and Experimental Toxicology, 2023, 42: 09603271231185774.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Analytical Cellular Pathology-Cellular Oncology
发表日期
2022-09-22
卷期
第 2022 卷
页码
5632164
DOI
10.1155/2022/5632164
语言
ENGLISH
期刊等级
4区
成果收录
SCIE

作者

  • L

    Li, Caihong (通讯) (第一作者)

    1 · china three gorges univ

  • W

    Wang, Qin

    1 · china three gorges univ

查看全部 4 位作者收起作者
  • L

    Luo, Youzhen

    1 · china three gorges univ

  • X

    Xiang, Juan

    1 · china three gorges univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417